Four out of ten patients are not taking statins regularly during the 12 months after an acute coronary event
NZ Literature Abstract
posted by Research Admin on 27 October 2011
Recommended
Authors
Simon Thornley
Roger J. Marshall
Wing Cheuk Chan
Andrew J. Kerr
Jeff Harrison
Gary Jackson
Sue Crengle
Craig Wright
Susan Wells
Rod T. Jackson
Year of Publication
2012
Source
European Journal of Cardiovascular Prevention & Rehabilitation 19(3), 349-357
Publication Type
Journal article (peer reviewed)
Publication Status
Completed
Abstract
In this retrospective cohort study, the authors investigated dispensing rates for statins after hospital discharge for acute CHD event. Based on the results of the study, the authors conclude that "in a setting with few barriers to statin treatment, about 40% of patients had suboptimal statin dispensing during the year after hospital treatment for CHD. This study has identified four significant categories of suboptimal adherence that could inform quality improvement programmes".
Type of Study
Retrospective cohort study
How to Access
To read the full abstract and for information on how to access the full text, go to: http://cpr.sagepub.com/content/19/3/349 or contact your local or organisational library for assistance.
by Mo Dunn
from Mid Central
Member since 13 Oct 2010
21 posts • Report
"40% suboptimal adherence to taking statins....".
Since Statins have been found to be of little value in the prevention of death from heart attack, why is it still being prescribed?
We all now know that cholesterol is not the cause of heart disease but is in fact of vital importance to our health and wellbeing. So why is it still being advocated as a so-called treatment?
Along with that the numerous side effects such as cognitive impairment, memory loss, irritability and rhabdomyolysis, would make it a less than optimal treatment, surely?.